受强制性开放获取政策约束的文章 - György Németh了解详情
可在其他位置公开访问的文章：9 篇
An 8-week randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of cariprazine in patients with bipolar I depression
S Durgam, W Earley, A Lipschitz, H Guo, I Laszlovszky, G Németh, E Vieta, ...
American Journal of Psychiatry 173 (3), 271-281, 2016
强制性开放获取政策： US National Institutes of Health, Canadian Institutes of Health Research …
Cariprazine treatment of bipolar depression: a randomized double-blind placebo-controlled phase 3 study
W Earley, MV Burgess, L Rekeda, R Dickinson, B Szatmári, G Németh, ...
American Journal of Psychiatry 176 (6), 439-448, 2019
强制性开放获取政策： Canadian Institutes of Health Research
Cariprazine in the treatment of schizophrenia: a proof-of-concept trial
S Durgam, RE Litman, K Papadakis, D Li, G Németh, I Laszlovszky
International clinical psychopharmacology 31 (2), 61-68, 2016
强制性开放获取政策： US National Institutes of Health
Cariprazine augmentation to antidepressant therapy in major depressive disorder: results of a randomized, double-blind, placebo-controlled trial
WR Earley, H Guo, G Németh, J Harsányi, ME Thase
Psychopharmacology bulletin 48 (4), 62, 2018
强制性开放获取政策： US National Institutes of Health
Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder
E Vieta, WR Earley, MV Burgess, S Durgam, C Chen, Y Zhong, ...
International clinical psychopharmacology 34 (2), 76-83, 2019
强制性开放获取政策： Government of Spain
The improvement of motor symptoms in Huntington’s disease during cariprazine treatment
R Csehi, V Molnar, M Fedor, V Zsumbera, A Palasti, K Acsai, Z Grosz, ...
Orphanet Journal of Rare Diseases 18 (1), 375, 2023
强制性开放获取政策： Hungarian Scientific Research Fund
Population pharmacogenomics and personalized medicine research in Hungary: Achievements and lessons learned
C Sipeky, G Keri, A Kiss, L Kopper, A Matolcsy, J Timar, MJ Molnar, ...
Current Pharmacogenomics and Personalized Medicine (Formerly Current …, 2010
强制性开放获取政策： Hungarian Scientific Research Fund
Cariprazine’s efficacy in treating depressive symptoms–pooled data from schizophrenia, bipolar depression and major depression trials
RS McIntyre, R Csehi, G Németh
European Psychiatry 66 (S1), S297-S298, 2023
强制性开放获取政策： Canadian Institutes of Health Research, 国家自然科学基金委员会
Long-term safety and tolerability of cariprazine as adjunctivetherapy in major depressive disorder
E Vieta i Pascual, W Earley, MV Burgess, S Durgam, C Chen, Y Zhong, ...
International Clinical Psychopharmacology, 2019, vol. 34, num. 2, p. 76-83, 2019
强制性开放获取政策： Government of Spain
出版信息和资助信息由计算机程序自动确定